Alliance for Pandemic Preparedness

September 28, 2020

Prevalence of SARS-CoV-2 Antibodies in a Large Nationwide Sample of Patients on Dialysis in the USA: A Cross-Sectional Study

Category:

Topic:

Keywords (Tags):

  • In a large sample of US adults who received dialysis (n=28,503), the seroprevalence of antibodies against SARS-CoV-2 was 8.0%, ranging from 3.5% in the west to 27.2% in the northeast. Seropositivity was higher in neighborhoods with predominantly non-Hispanic Black (OR=3.9) and Hispanic (OR=2.3) residents (vs white) and neighborhoods in the highest population density quintile (OR=10.3) (vs lowest quintile). Counties with mobility restrictions reducing workplace visits by at least 5% in early March, 2020 had lower seropositivity in July, 2020 than counties with reductions of less than 5% (OR=0.4).

Anand et al. (Sept 25, 2020). Prevalence of SARS-CoV-2 Antibodies in a Large Nationwide Sample of Patients on Dialysis in the USA: A Cross-Sectional Study. The Lancet. https://doi.org/10.1016/S0140-6736(20)32009-2